Author

Julie Overbaugh

Fred Hutch Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Amit SharmaiD· 2 shared A. Magedson· 1 shared Anna Smith· 1 shared Anuja Pimplapure· 1 shared C. I. Stoddard· 1 shared C. R. Wolf· 1 shared Daryl Humes· 1 shared Deepthi Kappala· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Amit SharmaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

HIV-1 envelope glycan loss links receptor adaptation and innate immune escape in SHIVs

Anna Smith, Haidyn Weight, Revansiddha Katte, Deepthi Kappala, Anuja Pimplapure, Vidya Mangala Prasad, Maolin Lu, Julie Overbaugh, Amit Sharma

This study shows that HIV-1 envelope glycan loss in SHIVs improves CD4 receptor utilization and reduces IFN restriction, linking receptor adaptation and immune escape.

bioRxiv · Oct 13, 2026 · PreprintMicrobiology

Epitope profiling reveals binding signatures of SARS-CoV-2 immune response and cross-reactivity with endemic HCoVs

C. I. Stoddard, J. Galloway, H. Y. Chu, M. M. Shipley, H. L. Itell, C. R. Wolf, J. K. Logue, A. Magedson, K. Sung, M. Garrett, K. H. Crawford, U. Laserson, F. A. Matsen, Julie Overbaugh

This study maps SARS-CoV-2 antibody epitopes and identifies cross-reactive sequences with endemic HCoVs in COVID-19 patients.

bioRxiv · Oct 29, 2020 · PreprintImmunology

Lineage-dependent differences and the role of IFITM3 in the type-I interferon-induced restriction of Zika virus

Theodore Gobillot, Daryl Humes, Amit Sharma, Julie Overbaugh

This study shows African-lineage Zika virus strains are more resistant to type-I interferon than Asian-lineage strains, and IFITM3 does not fully explain IFN-I restriction.

bioRxiv · Oct 29, 2018 · PreprintMicrobiology